Literature DB >> 23933528

Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.

Rukhsana Sultana1, Mauro Baglioni2, Roberta Cecchetti2, Jian Cai3, Jon B Klein3, Patrizia Bastiani2, Carmelinda Ruggiero2, Patrizia Mecocci4, D Allan Butterfield5.   

Abstract

Alzheimer disease (AD) is an age-related neurodegenerative condition. AD is histopathologically characterized by the presence of three main hallmarks: senile plaques (rich in amyloid-β peptide), neuronal fibrillary tangles (rich in phosphorylated tau protein), and synapse loss. However, definitive biomarkers for this devastating disease in living people are still lacking. In this study, we show that levels of oxidative stress markers are significantly increased in the mitochondria isolated from lymphocytes of subjects with mild cognitive impairment (MCI) compared to cognitively normal individuals. Further, an increase in mitochondrial oxidative stress in MCI is associated with MMSE score, vitamin E components, and β-carotene. Further, a proteomics approach showed that alterations in the levels of thioredoxin-dependent peroxide reductase, myosin light polypeptide 6, and ATP synthase subunit β might be important in the progression and pathogenesis of AD. Increased understanding of oxidative stress and protein alterations in easily obtainable peripheral tissues will be helpful in developing biomarkers to combat this devastating disorder.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Free radicals; Lymphocytes; Mild cognitive impairment; Mitochondria; Oxidative stress; Peripheral biomarker; Proteomics

Mesh:

Substances:

Year:  2013        PMID: 23933528      PMCID: PMC3849349          DOI: 10.1016/j.freeradbiomed.2013.08.001

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  65 in total

Review 1.  Isolation and subfractionation of mitochondria from animal cells and tissue culture lines.

Authors:  Francesco Pallotti; Giorgio Lenaz
Journal:  Methods Cell Biol       Date:  2007       Impact factor: 1.441

Review 2.  Rethinking Alzheimer's disease therapy: are mitochondria the key?

Authors:  Maria Ankarcrona; Francesca Mangialasche; Bengt Winblad
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

Authors:  Debra Boyd-Kimball; Hafiz Mohmmad Abdul; Tanea Reed; Rukhsana Sultana; D Allan Butterfield
Journal:  Chem Res Toxicol       Date:  2004-12       Impact factor: 3.739

4.  Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.

Authors:  Patrizia Mecocci; M Cristina Polidori; Antonio Cherubini; Tiziana Ingegni; Paola Mattioli; Marco Catani; Patrizia Rinaldi; Roberta Cecchetti; Wilhelm Stahl; Umberto Senin; M Flint Beal
Journal:  Arch Neurol       Date:  2002-05

5.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

6.  Vimentin supports mitochondrial morphology and organization.

Authors:  Ho Lam Tang; Hong Lok Lung; Ka Chun Wu; Anh-Huy Phan Le; Ho Man Tang; Ming Chiu Fung
Journal:  Biochem J       Date:  2008-02-15       Impact factor: 3.857

Review 7.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

8.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells.

Authors:  Pamela Lopert; Brian J Day; Manisha Patel
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more
  19 in total

Review 1.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

Review 2.  Environmental exposure and mitochondrial epigenetics: study design and analytical challenges.

Authors:  Hyang-Min Byun; Andrea A Baccarelli
Journal:  Hum Genet       Date:  2014-01-09       Impact factor: 4.132

Review 3.  Inflammation and programmed cell death in Alzheimer's disease: comparison of the central nervous system and peripheral blood.

Authors:  Beatrice Macchi; Francesca Marino-Merlo; Caterina Frezza; Salvatore Cuzzocrea; Antonio Mastino
Journal:  Mol Neurobiol       Date:  2014-01-21       Impact factor: 5.590

Review 4.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

Review 5.  Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass.

Authors:  David J Bonda; Xinglong Wang; Hyoung-Gon Lee; Mark A Smith; George Perry; Xiongwei Zhu
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

Review 6.  Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.

Authors:  D Allan Butterfield; Erika M Palmieri; Alessandra Castegna
Journal:  Expert Rev Proteomics       Date:  2016       Impact factor: 3.940

Review 7.  Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer's Disease.

Authors:  Giusy Tassone; Arian Kola; Daniela Valensin; Cecilia Pozzi
Journal:  Life (Basel)       Date:  2021-04-24

Review 8.  Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.

Authors:  D Allan Butterfield; Barry Halliwell
Journal:  Nat Rev Neurosci       Date:  2019-03       Impact factor: 38.755

Review 9.  Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics.

Authors:  Aaron Ritter; Jeffrey Cummings
Journal:  Front Neurol       Date:  2015-08-31       Impact factor: 4.003

10.  Altered proteolysis in fibroblasts of Alzheimer patients with predictive implications for subjects at risk of disease.

Authors:  Alessandra Mocali; Nunzia Della Malva; Claudia Abete; Vito Antonio Mitidieri Costanza; Antonio Bavazzano; Vieri Boddi; Luis Sanchez; Sandra Dessì; Alessandra Pani; Francesco Paoletti
Journal:  Int J Alzheimers Dis       Date:  2014-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.